Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 236
- Registration Number
- NCT03971383
- Locations
- 🇨🇳
The Second People's Hospital of Fujian Province, Fuzhou, Fujian, China
Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
- Conditions
- Interventions
- First Posted Date
- 2019-05-13
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT03947411
- Locations
- 🇨🇳
The First Affliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT03641794
- Locations
- 🇨🇳
PKUCare Luzhong Hospital, Zibo, Shandong, China
Study of Aolanti Weikang Tablets in Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2017-11-30
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT03358485
- Locations
- 🇨🇳
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, China
Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis
- Conditions
- Interventions
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT03134443
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis
- Conditions
- Interventions
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT03132610
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis
- Conditions
- Interventions
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT03132623
- Locations
- 🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
A Study of SC10914 in Patients With Advanced Solid Tumors
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT02940132
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.
- Conditions
- Interventions
- First Posted Date
- 2016-10-19
- Last Posted Date
- 2017-12-06
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT02937857
- Locations
- 🇨🇳
Guangzhou women and children health care center, Guangzhou, Guangdong, China
Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth Disease
- Conditions
- Interventions
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 230
- Registration Number
- NCT01554930
- Locations
- 🇨🇳
Liuzhou People's Hospital, Liuzhou, Guangxi, China
🇨🇳Handan Maternal and Child Health Care Hospital, Handan, Hebei, China
🇨🇳Jiangxi Children's Hospital, Nanchang, Jiangxi, China